Prognostication using SCORTEN in SJS and TEN

Often in cases of severe injury or pathology, unclear prognosis and the lack of availability of concrete mortality measurements make goals of care (GOC) discussions with patients and their families difficult. Palliative care providers are sometimes involved in the care of patients with severe dermatological illnesses, such as Steven ’s Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), and knowledge of the prognostic tools used in these conditions is helpful. The incidence of SJS is estimated at 1-6 cases/million people and the incidence of TEN is 0.4-1.2 cases/million people; the mortality rates are 1-5% and 25-35%, respectively (1).

Source: Journal of Pain and Symptom Management - September 28, 2018 Category: Palliative Care Authors: Olivia M. Seecof, John Liantonio Source Type: research